X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Aurobindo Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs AUROBINDO PHARMA - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD AUROBINDO PHARMA MERCK LTD/
AUROBINDO PHARMA
 
P/E (TTM) x 25.1 19.0 131.9% View Chart
P/BV x 2.8 6.2 45.4% View Chart
Dividend Yield % 1.0 0.3 300.3%  

Financials

 MERCK LTD   AUROBINDO PHARMA
EQUITY SHARE DATA
    MERCK LTD
Dec-16
AUROBINDO PHARMA
Mar-16
MERCK LTD/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0601,541 68.8%   
Low Rs623582 107.0%   
Sales per share (Unadj.) Rs632.4237.5 266.3%  
Earnings per share (Unadj.) Rs45.733.9 135.0%  
Cash flow per share (Unadj.) Rs62.340.6 153.6%  
Dividends per share (Unadj.) Rs11.002.50 440.0%  
Dividend yield (eoy) %1.30.2 554.9%  
Book value per share (Unadj.) Rs388.8120.6 322.4%  
Shares outstanding (eoy) m16.60585.17 2.8%   
Bonus/Rights/Conversions -PREF-  
Price / Sales ratio x1.34.5 29.8%   
Avg P/E ratio x18.431.3 58.7%  
P/CF ratio (eoy) x13.526.2 51.6%  
Price / Book Value ratio x2.28.8 24.6%  
Dividend payout %24.17.4 326.0%   
Avg Mkt Cap Rs m13,969621,041 2.2%   
No. of employees `0001.613.3 11.9%   
Total wages/salary Rs m1,48715,508 9.6%   
Avg. sales/employee Rs Th6,631.910,457.6 63.4%   
Avg. wages/employee Rs Th939.21,167.1 80.5%   
Avg. net profit/employee Rs Th479.41,491.6 32.1%   
INCOME DATA
Net Sales Rs m10,498138,961 7.6%  
Other income Rs m2421,663 14.6%   
Total revenues Rs m10,741140,624 7.6%   
Gross profit Rs m1,13532,056 3.5%  
Depreciation Rs m2763,926 7.0%   
Interest Rs m02,568 0.0%   
Profit before tax Rs m1,10227,225 4.0%   
Minority Interest Rs m039 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3437,444 4.6%   
Profit after tax Rs m75919,820 3.8%  
Gross profit margin %10.823.1 46.9%  
Effective tax rate %31.127.3 113.9%   
Net profit margin %7.214.3 50.7%  
BALANCE SHEET DATA
Current assets Rs m6,410100,015 6.4%   
Current liabilities Rs m8,82874,759 11.8%   
Net working cap to sales %-23.018.2 -126.8%  
Current ratio x0.71.3 54.3%  
Inventory Days Days58107 53.7%  
Debtors Days Days38110 35.0%  
Net fixed assets Rs m1,40652,350 2.7%   
Share capital Rs m166585 28.4%   
"Free" reserves Rs m6,28667,707 9.3%   
Net worth Rs m6,45570,567 9.1%   
Long term debt Rs m08,472 0.0%   
Total assets Rs m8,828156,994 5.6%  
Interest coverage xNM11.6-  
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.20.9 134.3%   
Return on assets %8.614.3 60.3%  
Return on equity %11.828.1 41.9%  
Return on capital %17.137.7 45.2%  
Exports to sales %8.351.0 16.2%   
Imports to sales %21.018.8 111.6%   
Exports (fob) Rs m86970,927 1.2%   
Imports (cif) Rs m2,20926,193 8.4%   
Fx inflow Rs m95971,015 1.4%   
Fx outflow Rs m2,61228,799 9.1%   
Net fx Rs m-1,65342,216 -3.9%   
CASH FLOW
From Operations Rs m1,07017,596 6.1%  
From Investments Rs m-750-13,801 5.4%  
From Financial Activity Rs m-150-198 75.5%  
Net Cashflow Rs m1713,597 4.8%  

Share Holding

Indian Promoters % 0.0 54.1 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 8.0 228.9%  
FIIs % 1.0 27.7 3.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 10.2 285.3%  
Shareholders   28,591 69,601 41.1%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   SUN PHARMA  WYETH LTD  ABBOTT INDIA  FULFORD INDIA  DR. REDDYS LAB  

Compare MERCK LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Tata Stocks Rally(Closing)

Indian share markets continued to trade range bound in afternoon session with market participants awaiting the US Federal Reserve's policy statement this week.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

India's Big and Messy Real Estate Ponzi Scheme, Just Got Messier(Vivek Kaul's Diary)

Sep 11, 2017

The question is, whether real estate buyers are financial creditors or not.

Kim Jong Un Is Keeping Traders Busy(Daily Profit Hunter)

Sep 6, 2017

You shouldn't worry about North Kore, War or Market Corrections.

180,000%: The Returns That Could Have Been(The 5 Minute Wrapup)

Sep 7, 2017

For successful investing in small caps, it's important to know when not to press the panic button.

How To Link Aadhaar With Your Mutual Fund Investments(Outside View)

Sep 11, 2017

The Government has extended the linking of the unique Aadhaar number to nearly all financial transactions.

Home Prices Chart a Steady Rise(Chart Of The Day)

Sep 7, 2017

Home prices data throws up a positive surprise.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Sep 19, 2017 03:36 PM

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD - NATCO PHARMA COMPARISON

COMPARE MERCK LTD WITH

MARKET STATS